Development and validation of the Lymphedema Symptom and Intensity Survey-Arm

Ridner, Sheila H.; Dietrich, Mary S.

doi:10.1007/s00520-015-2684-y

Cited by 47 publications

(50 citation statements)

References 24 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The Lymphedema Symptom Intensity and Distress Survey – Arm (LSIDS-A) is a 36-item instrument that assesses arm lymphedema and related symptoms. 35 There is excellent reliability for overall intensity and distress scores of the LSIDS-A (Cronbach alpha values = .93 and .94, respectively) as well as sexuality and mood (Cronbach alpha = .90). There was moderate test-retest reliability for function intensity (ICC = .69) and distress scores (ICC = .75).…”

Section: Clinical Examination and Patient-reported Symptom Assessmentmentioning

confidence: 93%

Diagnosis of Upper Quadrant Lymphedema Secondary to Cancer: Clinical Practice Guideline From the Oncology Section of the American Physical Therapy Association

et al. 2017

View full text Add to dashboard Cite

The Oncology Section of the American Physical Therapy Association (APTA) developed a clinical practice guideline to aid the clinician in diagnosing secondary upper quadrant cancer-related lymphedema. Following a systematic review of published studies and a structured appraisal process, recommendations were written to guide the physical therapist and other health care clinicians in the diagnostic process. Overall clinical practice recommendations were formulated based on the evidence for each diagnostic method and were assigned a grade based on the strength of the evidence for different patient presentations and clinical utility. In an effort to maximize clinical applicability, recommendations were based on the characteristics as to the location and stage of a patient's upper quadrant lymphedema.

show abstract

Section: Clinical Examination and Patient-reported Symptom Assessmentmentioning

confidence: 93%

Diagnosis of Upper Quadrant Lymphedema Secondary to Cancer: Clinical Practice Guideline From the Oncology Section of the American Physical Therapy Association

et al. 2017

View full text Add to dashboard Cite

show abstract

“…The Lymphedema Symptom Intensity and Distress Survey–Arm (LSIDS-A) is a 36-item instrument that assesses arm lymphedema and related symptoms 35. There is excellent reliability for overall intensity and distress scores of the LSIDS-A (Cronbach α values = 0.93 and 0.94, respectively), as well as sexuality and mood (Cronbach α = 0.90).…”

Section: Clinical Examination and Patient-reported Symptom Assessmentsmentioning

confidence: 99%

Diagnosis of Upper-Quadrant Lymphedema Secondary to Cancer: Clinical Practice Guideline From the Oncology Section of APTA

Levenhagen

Davies

Perdomo

et al. 2017

Rehabilitation Oncology

View full text Add to dashboard Cite

show abstract

“…29,30 One such tool that is currently available is the Lymphedema Symptom and Intensity Survey Arm. 31 Therapists also reported that the assessments were used to estimate tissue changes. Palpation and/or the combined findings from BIS and circumference measurements helped elucidate tissue changes.…”

Section: Discussionmentioning

confidence: 99%

Assessment of Upper Limb Lymphedema: A Qualitative Study Exploring Clinicians' Clinical Reasoning

Sierla

Dylke

Shaw

et al. 2021

Lymphatic Research and Biology

View full text Add to dashboard Cite

Background: A variety of objective and subjective assessments are available for clinical assessment of lymphedema. The aim of this study was to explore the clinical reasoning underpinning the assessment of upper limb lymphedema by experienced lymphedema clinicians. Methods and Results: Semistructured, individual, interviews were conducted with lymphedema therapists (n = 14) from a variety of treatment settings. These interviews were conducted after observations of these therapists assessing patients with lymphedema and focused on: (1) the therapists' rationale for the assessments selected, (2) how the data were analyzed, and (3) how the information was then used. Assessment selection was guided by the purpose of the visit, patient preference, resources, and time available. Subjective measures of visible and palpated tissue changes were used to target treatment, and objective measures of circumference and bioimpedance spectroscopy and patient report of symptoms informed treatment evaluation and disease progression. Objective data collected were primarily analyzed for interlimb difference and change between appointments. Conclusions: A range of clinical assessments were used in the evaluation of lymphedema to detect the presence of lymphedema, estimate the extent of soft tissue change, understand the patient experience of lymphedema, and evaluate treatment response. A primary determinant for the collection of objective measures was the appointment duration. Current methods of data analysis and reporting do not facilitate the review of change over time.

show abstract

Development and validation of the Lymphedema Symptom and Intensity Survey-Arm

Cited by 47 publications

References 24 publications

Diagnosis of Upper Quadrant Lymphedema Secondary to Cancer: Clinical Practice Guideline From the Oncology Section of the American Physical Therapy Association

Diagnosis of Upper Quadrant Lymphedema Secondary to Cancer: Clinical Practice Guideline From the Oncology Section of the American Physical Therapy Association

Diagnosis of Upper-Quadrant Lymphedema Secondary to Cancer: Clinical Practice Guideline From the Oncology Section of APTA

Assessment of Upper Limb Lymphedema: A Qualitative Study Exploring Clinicians' Clinical Reasoning

Contact Info

Product

Resources

About